Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥3.41T2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥1.14T2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥3.98T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.90T2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥1.02T2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥48.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income−¥69.7bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥218.2bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥65.1bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥39.2bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥82.8bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥290.4bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥208.2bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥61.0bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥17.0bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥56.9bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥177.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥122.1bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥37.0bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥44.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income−¥46.7bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥209.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥147.3bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥45.3bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥5.86Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.57Tat 2022-03-31Cons.Assets IFRS
Total assets¥5.46Tat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.96Tat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥3.73Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.90Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥1.84Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.71Tat 2021-12-31Cons.Equity IFRS
Net assets / equity¥1.57Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.50Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.35Tat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥257.0bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥245.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥259.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥349.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥174.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥346.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥248.0bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥174.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥128.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥140.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥8.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥336.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥200.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥11.992022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-40.022022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥124.682021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥85.952021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥26.012021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥11.552022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-40.022022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥115.032021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥79.062021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.932021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio25.5%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.7%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥309.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥162.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥147.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥11.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥230.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥230.7bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥9.7bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.14T
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.10T
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥37.2bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.3bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue2022-04-01 → 2022-12-31¥332.0bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue external2022-04-01 → 2022-12-31¥331.6bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥416m
jpcrp040300-q3r_E00808-000Health Carereportable segmentsegment profit2022-04-01 → 2022-12-31¥18.5bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue2022-04-01 → 2022-12-31¥873.0bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue external2022-04-01 → 2022-12-31¥866.4bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentsegment profit2022-04-01 → 2022-12-31¥84.3bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥983.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥944.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥38.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥54.1bn
—segment totalrevenue2022-04-01 → 2022-12-31¥3.33T
—segment totalrevenue external2022-04-01 → 2022-12-31¥3.24T
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥83.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥176.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥3.64T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥3.41T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥230.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥187.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥279.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥130.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥148.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31¥10.3bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥223.8bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥223.8bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥10.8bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue2021-04-01 → 2021-12-31¥953.7bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue external2021-04-01 → 2021-12-31¥921.8bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥31.9bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentsegment profit2021-04-01 → 2021-12-31¥83.5bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue2021-04-01 → 2021-12-31¥312.4bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue external2021-04-01 → 2021-12-31¥312.1bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥247m
jpcrp040300-q3r_E00808-000Health Carereportable segmentsegment profit2021-04-01 → 2021-12-31¥4.6bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue2021-04-01 → 2021-12-31¥691.5bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue external2021-04-01 → 2021-12-31¥686.6bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥5.0bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentsegment profit2021-04-01 → 2021-12-31¥73.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥887.4bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥848.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥38.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥57.5bn
—segment totalrevenue2021-04-01 → 2021-12-31¥2.84T
—segment totalrevenue external2021-04-01 → 2021-12-31¥2.77T
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥75.6bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥219.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥3.12T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥2.90T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥223.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥229.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 925
ItemContextValueUnit
Gain on sale of investments in subsidiaries and associates adjustments to profit before tax IFRSPrior1YTDDuration1886000000JPY
Gain on sale of investments in subsidiaries and associates adjustments to profit before tax IFRSCurrentYTDDuration2233000000JPY
Gain on sale of fixed assets adjustments to profit before tax IFRSPrior1YTDDuration8420000000JPY
Gain on sale of fixed assets adjustments to profit before tax IFRSCurrentYTDDuration712000000JPY
Impairment losses adjustments to profit before tax IFRSPrior1YTDDuration2797000000JPY
Impairment losses adjustments to profit before tax IFRSCurrentYTDDuration87746000000JPY
Provision for loss on plant closure IFRSPrior1YTDDuration-JPY
Provision for loss on plant closure IFRSCurrentYTDDuration31214000000JPY
Early retirement program expenses adjustments to profit before tax IFRSPrior1YTDDuration1871000000JPY
Early retirement program expenses adjustments to profit before tax IFRSCurrentYTDDuration4292000000JPY
Provision for loss on litigation adjustments to profit before tax IFRSPrior1YTDDuration-JPY
Provision for loss on litigation adjustments to profit before tax IFRSCurrentYTDDuration3550000000JPY
Loss on arbitration award IFRSPrior1YTDDuration-JPY
Loss on arbitration award IFRSCurrentYTDDuration3542000000JPY
Loss on sale and retirement of fixed assets adjustments to profit before tax IFRSPrior1YTDDuration3579000000JPY
Loss on sale and retirement of fixed assets adjustments to profit before tax IFRSCurrentYTDDuration2448000000JPY
Other adjustments to profit before tax IFRSPrior1YTDDuration2763000000JPY
Other adjustments to profit before tax IFRSCurrentYTDDuration1801000000JPY
Operating profit loss IFRSPrior1YTDDuration218237000000JPY
Operating profit loss IFRSCurrentYTDDuration48622000000JPY
Finance income IFRSPrior1YTDDuration6797000000JPY
Finance income IFRSCurrentYTDDuration12033000000JPY
Finance costs IFRSPrior1YTDDuration16857000000JPY
Finance costs IFRSCurrentYTDDuration21448000000JPY
Profit loss before tax IFRSPrior1YTDDuration208177000000JPY
Profit loss before tax IFRSCurrentYTDDuration39207000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-02-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第18期第3四半期(自 2022年10月1日 至 2022年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)三菱ケミカルグループ株式会社
Company name in english cover pageFilingDateInstantMitsubishi Chemical Group Corporation
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)執行役社長    ジョンマーク・ギルソン
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内一丁目1番1号
Telephone number address of registered headquarter cover pageFilingDateInstant(03)6748-7200
Name of contact person address of registered headquarter cover pageFilingDateInstantText · Plus
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内一丁目1番1号
Telephone number nearest place of contact cover pageFilingDateInstant(03)6748-7200
Name of contact person nearest place of contact cover pageFilingDateInstantText · Plus
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00808
Fund codeFilingDateInstant-
Security codeFilingDateInstant41880
Filer name in japaneseFilingDateInstant
Original text (Japanese)三菱ケミカルグループ株式会社
Filer name in englishFilingDateInstantMitsubishi Chemical Group Corporation
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass